Our Foundation
Where We've Been.
Congratulations to our TBBCF 2019 top fundraisers By ELLEN SWERCEWSKI As we prepare for our 15th annual walk in October this year, we pause to take a look at our 2019 top fundraisers. These are individuals and groups who go above and beyond and give more than 100 percent in fundraising efforts. They host events, […]
A memorial tribute to Westerly’s living legend, Angie Smith By SANDY MANISCALCO A regional “living-legend” and Terri Brodeur Breast Cancer Foundation super supporter, Angela (Angie) Smith, passed away on Feb. 29, 2020. “She was a rare gem and left us on Leap Day, commonly referred to as ‘leap of kindness’ day in recent years. How […]
Plans continue for 15th annual Walk Across Southeastern Connecticut We hope all is well with our supporters, families and friends, as we face this new reality of social distancing and constant hand-washing. COVID-19 has made us all stop and think before hugging, shaking hands and gathering in groups. Because of the uncertainty of the times, things […]
TBBCF awards 4 new research grants By KATHEEN EDGECOMB The Terri Brodeur Breast Cancer Foundation has awarded $400,000 in grants to four researchers who are looking for a cure for breast cancer and better ways to treat the disease in those already diagnosed. The foundation’s scientific advisory board chaired by founding member Nicholas Saccomano, PhD, […]
Big Y donates $3,772 through their Partners of Hope and reusable shopping bag campaigns By ELLEN SWERCEWSKI Big Y has donated $3,000 to the Terri Brodeur Breast Cancer Foundation as part of its annual Partners of Hope Campaign, and another $772 for the Big Y reusable shopping bag campaign. On Feb. 14, 2020, Big Y […]
Jennifer L. Guerriero, PhD Dana-Farber Cancer Institute – Harvard Medical School Modulating the immune system as an anti-cancer strategy has shown great promise in some types of cancer, however there has been limited responses in breast cancer. While the main focus of immunotherapy has been on the adaptive immune system, namely T cells, harnessing innate […]
Sheheryar K. Kabraji, BM BCh Dana-Farber Cancer Institute – Harvard Medical School While effective HER2-targeting drugs have greatly improved outcomes for patients with HER2-positive (HER2+) breast cancer, relapse and recurrence still occur. When HER2+ breast cancer returns after treatment, it is because some cancer cells survive killing, and are known as minimal residual disease (MRD). To […]
Naiara Perurena, PhD, PharmD Brigham and Women’s Hospital – Harvard Medical School Around 15-20% of breast cancers are characterized by the amplification or overexpression of the receptor tyrosine kinase HER2 and are therefore classified as HER2-positive. In these tumors, HER2 drives tumor formation and progression by activating an oncogenic signaling cascade. Fortunately, the development of […]
Jan Remsik, PhD, PharmD Memorial Sloan Kettering Cancer Center Leptomeningeal metastasis (LM), or the spread of tumor cells into the cerebrospinal fluid, is an increasingly common complication of cancer that results in rapid neurologic disability and death. Colonization of leptomeningeal space by cancer cells can take years or even decades after primary cancer diagnosis. The […]
Grand Wine & Spirits’ Chuck Bowe has raised over $60k for TBBCF since 2011 By SANDY MANISCALCO Grand Wine & Spirits (GWS), a faithful supporter of the Terri Brodeur Breast Cancer Foundation (TBBCF) since 2011, continued its dedication this year and raised $8,324 surpassing its 2019 breast cancer awareness fundraising campaign goal. On Thursday, Jan. […]
our sponsors
Platinum & Diamond Partners
